Tech Company Financing Transactions

VistaGen Therapeutics Funding Round

VistaGen Therapeutics closed a $4.8 million funding round on 9/24/2018. Backers included private investors.

Transaction Overview

Announced On
9/24/2018
Transaction Type
Venture Equity
Amount
$4,778,750
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 33 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
343 Allerton Ave.
South San Francisco, CA 94080
USA
Email Address
Overview
VistaGen Therapeutics is a biopharmaceutical company pioneering the use of embryonic stem cells (ES cells) for drug discovery and development and predictive toxicology.
Profile
VistaGen Therapeutics LinkedIn Company Profile
Social Media
VistaGen Therapeutics Company Twitter Account
Company News
VistaGen Therapeutics News
Facebook
VistaGen Therapeutics on Facebook
YouTube
VistaGen Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Shawn Singh
  Shawn Singh LinkedIn Profile  Shawn Singh Twitter Account  Shawn Singh News  Shawn Singh on Facebook
Chief Financial Officer
Jerrold Dotson
  Jerrold Dotson LinkedIn Profile  Jerrold Dotson Twitter Account  Jerrold Dotson News  Jerrold Dotson on Facebook
Chief Medical Officer
Mark Smith
  Mark Smith LinkedIn Profile  Mark Smith Twitter Account  Mark Smith News  Mark Smith on Facebook
Chief Scientific Officer
Ralph Snodgrass
  Ralph Snodgrass LinkedIn Profile  Ralph Snodgrass Twitter Account  Ralph Snodgrass News  Ralph Snodgrass on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/24/2018: Tvardi Therapeutics venture capital transaction
Next: 9/24/2018: Citybase venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary